Self Study Management of Cirrhosis-Related Complications
Sign In or Register to get started
Management of Cirrhosis-Related Complications
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Lesson, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Lesson
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 4 Overview
Diagnosis and Management of Hepatic Encephalopathy - 0%Topic 1
BackgroundActivities- 0%Topic 2
Clinical FeaturesActivities- 0%Topic 3
Diagnosis and TestingActivities- 0%Topic 4
Approach to the Management of Hepatic EncephalopathyDiagnosis and Management of Hepatic Encephalopathy Overview
About this Lesson
Last Updated: March 4th, 2024CNE/CMEContinuing Education
This lesson qualifies for:- 1.0 CME AMA PRA Category 1 Credit™, or
- 1.0 CNE contact hour and 1.0 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: August 29th, 2013CNE and CME Review: March 15th, 2024CNE and CME Expiration: March 10th, 2027 (4th Edition)
View CE NoticesSteps to acquire a Certificate for this Lesson:
1Study
all Topics2Quiz
Score 80%+3Give Feedback
Complete survey4Print Certificate
4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Diagnosis and Management of Hepatic Encephalopathy and available until March 14th, 2024.Learning Objectives
- List the clinical features of persons with hepatic encephalopathy
- Describe specific diagnostic tests used to diagnose hepatic encephalopathy
- Summarize the approach to management of persons with hepatic encephalopathy
- Explain the rationale for using nonabsorbable disaccharides for the treatment of hepatic encephalopathy
- Discuss the role of antimicrobial therapy for the treatment of hepatic encephalopathy
Lesson Contributors
Authors
Jennifer Price, MD, PhDJennifer Price, MD, PhD
Professor of Medicine
Director, UCSF Viral Hepatitis Center
Division of GI and Hepatology
University of California, San FranciscoDisclosures:- Grants, Research support to Institution: Abbvie, Genentech, Vir Biotechnology, Zydus Pharmaceuticals
The relevant financial relationship was mitigated.Reviewers
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Associate Editor
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneDavid H. Spach, MDDavid H. Spach, MD
Editor-in-Chief
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
Easy access to every topic in the self-study lessons.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-monorepo-75ec26d4-2025-04-30-205728
Become a New User
Account Registration Benefits:
- Track your progress on the lessons
- Earn free CNE/CME/CE
- Earn Certificates of Completion
- Access to other free IDEA curricula
Create a free account to get started